Links

Tools

Export citation

Search in Google Scholar

Changes of serum protein glycosylation as marker in the differential diagnosis of hepatitis and liver cirrhosis

Journal article published in 2010 by B. P. Chatterjee, U. Chatterjee ORCID, G. Mondal
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

Infection with hepatitis B virus and/or hepatitis C virus is the major cause of liver cirrhosis and liver cancer. Although there are periodical physical and clinical assessments, liver function tests and ultrasonography, it often becomes difficult for accurate diagnosis of the above mentioned liver diseases. The present review discusses a non-invasive simple test based on glycosylation change in serum glycoproteins viz., alpha - fetoprotein (AFP), alphal-acid glycoprotein (AGP) for differential diagnosis among chronic hepatitis B (HBV), HBV with cirrhosis (HBV-LC j, hepatitis C cirrhosis (HCV-LC) and alcoholic cirrhosis (ALC) patients using lectin-based sandwich ELISA. Although, in general, hyperfucosylation, increased level, increased branching and sialylation including variation of sialic acid linkages have been observed in AFP and AGP in all patient groups, there has been subtle changes among these parameters. ALC showed highest level of AFP whereas HBV- LC showed highly/increased branching in both AFP and AGP/AFP in HCV-LC expressed predominantly a 2,3- linked sialic acid whereas AFP in HBV showed the predominance of α 2,6 linked sialic acid. Addition of these results to the conventional liver function markers significantly aid in differential diagnosis among hepatitis and liver cirrhosis.